JPH03103194A - Testing agent and testing tool - Google Patents
Testing agent and testing toolInfo
- Publication number
- JPH03103194A JPH03103194A JP23814889A JP23814889A JPH03103194A JP H03103194 A JPH03103194 A JP H03103194A JP 23814889 A JP23814889 A JP 23814889A JP 23814889 A JP23814889 A JP 23814889A JP H03103194 A JPH03103194 A JP H03103194A
- Authority
- JP
- Japan
- Prior art keywords
- peroxidase
- test agent
- test
- reaction
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 80
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 21
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 19
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 17
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 17
- 239000003381 stabilizer Substances 0.000 claims abstract description 16
- 239000007800 oxidant agent Substances 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims abstract description 11
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 claims abstract description 9
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000005843 halogen group Chemical group 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 150000001768 cations Chemical class 0.000 claims abstract description 4
- 239000013543 active substance Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 238000004040 coloring Methods 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 claims description 4
- SNCJAJRILVFXAE-UHFFFAOYSA-N 9h-fluorene-2,7-diamine Chemical compound NC1=CC=C2C3=CC=C(N)C=C3CC2=C1 SNCJAJRILVFXAE-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 4
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 10
- 239000008103 glucose Substances 0.000 abstract description 10
- -1 nitro, carboxyl Chemical group 0.000 abstract description 10
- 238000007254 oxidation reaction Methods 0.000 abstract description 8
- 238000003860 storage Methods 0.000 abstract description 7
- 230000003647 oxidation Effects 0.000 abstract description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 abstract description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000010323 ascorbic acid Nutrition 0.000 description 9
- 239000011668 ascorbic acid Substances 0.000 description 9
- 229960005070 ascorbic acid Drugs 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229940039227 diagnostic agent Drugs 0.000 description 6
- 239000000032 diagnostic agent Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 150000002432 hydroperoxides Chemical class 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004263 Guaiac resin Substances 0.000 description 2
- 229920000932 Gum guaicum Polymers 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- HCAUQPZEWLULFJ-UHFFFAOYSA-N benzo[f]quinoline Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=N1 HCAUQPZEWLULFJ-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 2
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019278 guaiac resin Nutrition 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Chemical class 0.000 description 2
- 239000002184 metal Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- QYIGOGBGVKONDY-UHFFFAOYSA-N 1-(2-bromo-5-chlorophenyl)-3-methylpyrazole Chemical compound N1=C(C)C=CN1C1=CC(Cl)=CC=C1Br QYIGOGBGVKONDY-UHFFFAOYSA-N 0.000 description 1
- XSZYESUNPWGWFQ-UHFFFAOYSA-N 1-(2-hydroperoxypropan-2-yl)-4-methylcyclohexane Chemical compound CC1CCC(C(C)(C)OO)CC1 XSZYESUNPWGWFQ-UHFFFAOYSA-N 0.000 description 1
- XGIDEUICZZXBFQ-UHFFFAOYSA-N 1h-benzimidazol-2-ylmethanethiol Chemical compound C1=CC=C2NC(CS)=NC2=C1 XGIDEUICZZXBFQ-UHFFFAOYSA-N 0.000 description 1
- JGBAASVQPMTVHO-UHFFFAOYSA-N 2,5-dihydroperoxy-2,5-dimethylhexane Chemical compound OOC(C)(C)CCC(C)(C)OO JGBAASVQPMTVHO-UHFFFAOYSA-N 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- SVNCRRZKBNSMIV-UHFFFAOYSA-N 3-Aminoquinoline Chemical compound C1=CC=CC2=CC(N)=CN=C21 SVNCRRZKBNSMIV-UHFFFAOYSA-N 0.000 description 1
- QYIMZXITLDTULQ-UHFFFAOYSA-N 4-(4-amino-2-methylphenyl)-3-methylaniline Chemical compound CC1=CC(N)=CC=C1C1=CC=C(N)C=C1C QYIMZXITLDTULQ-UHFFFAOYSA-N 0.000 description 1
- YRUPBAWWCPVHFT-UHFFFAOYSA-N 4-(4-hydroxyanilino)phenol Chemical compound C1=CC(O)=CC=C1NC1=CC=C(O)C=C1 YRUPBAWWCPVHFT-UHFFFAOYSA-N 0.000 description 1
- YGGTVPCTAKYCSQ-UHFFFAOYSA-N 6-methoxyquinolin-8-amine Chemical compound N1=CC=CC2=CC(OC)=CC(N)=C21 YGGTVPCTAKYCSQ-UHFFFAOYSA-N 0.000 description 1
- HFDLDPJYCIEXJP-UHFFFAOYSA-N 6-methoxyquinoline Chemical compound N1=CC=CC2=CC(OC)=CC=C21 HFDLDPJYCIEXJP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- WZKXBGJNNCGHIC-UHFFFAOYSA-N Leucomalachite green Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=CC=C1 WZKXBGJNNCGHIC-UHFFFAOYSA-N 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 229920001311 Poly(hydroxyethyl acrylate) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- GZLGNNHEHXBCBI-UHFFFAOYSA-L [Na+].[Na+].OC(=O)C(O)C(O)C(O)=O.[O-]C(=O)C(O)C(O)C([O-])=O Chemical compound [Na+].[Na+].OC(=O)C(O)C(O)C(O)=O.[O-]C(=O)C(O)C(O)C([O-])=O GZLGNNHEHXBCBI-UHFFFAOYSA-L 0.000 description 1
- DHCJUOOZDMXKGF-UHFFFAOYSA-L [Na+].[Na+].OC(=O)CC(O)(CC([O-])=O)C(O)=O.OC(=O)CC(O)(CC([O-])=O)C(O)=O Chemical compound [Na+].[Na+].OC(=O)CC(O)(CC([O-])=O)C(O)=O.OC(=O)CC(O)(CC([O-])=O)C(O)=O DHCJUOOZDMXKGF-UHFFFAOYSA-L 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-LSOMNZGLSA-N cinchonine Chemical compound C1=CC=C2C([C@@H]([C@H]3N4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-LSOMNZGLSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- VDCRQFNOANTCGX-UHFFFAOYSA-L disodium;2,2-diheptyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCC VDCRQFNOANTCGX-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000013080 microcrystalline material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004986 phenylenediamines Chemical class 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- GAKHQUNCYOPYPD-UHFFFAOYSA-K tripotassium;hydron;phthalate Chemical compound [K+].[K+].[K+].OC(=O)C1=CC=CC=C1C([O-])=O.[O-]C(=O)C1=CC=CC=C1C([O-])=O GAKHQUNCYOPYPD-UHFFFAOYSA-K 0.000 description 1
- IJMZYCQOAGRRJC-UHFFFAOYSA-K trisodium butanedioate 4-hydroxy-4-oxobutanoate Chemical compound [Na+].[Na+].[Na+].OC(=O)CCC([O-])=O.[O-]C(=O)CCC([O-])=O IJMZYCQOAGRRJC-UHFFFAOYSA-K 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
く産業上の利用分野〉
本発明は、ヒドロペルオキシドまたは前反応によって生
ずる過酸化水素もしくは他のヒドロペルオキシドを、ベ
ルオキシグーゼ・またはペルオキシダーゼ様反応を用い
て測定する試験剤、またはペルオキシダーゼもしくはペ
ルオキシダーゼ作用物質を検出するための試験剤、特に
尿および血液中のブドウ糖の検出用ならびに尿、糞便お
よび液中の血液の検出用の試験剤およびこの試験剤を担
持した試験具に関する。Detailed Description of the Invention Industrial Field of Application The present invention relates to a test agent for measuring hydroperoxides or hydrogen peroxide or other hydroperoxides produced by a pre-reaction using a peroxidase- or peroxidase-like reaction; The present invention relates to a test agent for detecting peroxidase or a peroxidase-active substance, particularly for detecting glucose in urine and blood, and for detecting blood in urine, feces, and liquid, and a test device carrying this test agent.
く従来の技術〉
最近、迅速診断剤は、医学的ブラクティスおよび臨床試
験において著しく重要になっており、吸収性担体をベー
スとする迅速診断剤は重要である。 多くの場合、紙の
ような吸収性担体に検出反応に必要な薬剤を含浸させ、
これを体液中に浸漬すると、検出すべき物質が存在する
場合には呈色反応を生ずる。 医学的診断で非常に重要
になった迅速診断剤としては、例えば尿および血液中の
ブドウ糖検出用ならびに尿、糞便および液中の血液検出
用迅速診断剤がある。BACKGROUND OF THE INVENTION Recently, rapid diagnostic agents have become extremely important in medical practice and clinical trials, and rapid diagnostic agents based on absorbable carriers are important. In many cases, an absorbent carrier such as paper is impregnated with the drug necessary for the detection reaction.
When immersed in body fluids, a color reaction occurs if the substance to be detected is present. Rapid diagnostic agents that have become very important in medical diagnosis include, for example, rapid diagnostic agents for detecting glucose in urine and blood, and for detecting blood in urine, feces, and fluids.
この試験は、次の原理に基づいている。This test is based on the following principle.
体液中のブドウ糖を検出する際には、例えばグルコース
はグルコースオキシダーゼ(COD)によってグルコン
酸に酸化され、その際に空気中酸素は過酸化水素に還元
される。 この過酸化水素は、ペルオキシダーゼ(PO
D)またはペルオキシダーゼ作用性物質によって酸化呈
色指示薬を相応する色素に酸化し、その色の濃度が存在
するグルコース量の尺度である。When detecting glucose in body fluids, for example, glucose is oxidized to gluconic acid by glucose oxidase (COD), while atmospheric oxygen is reduced to hydrogen peroxide. This hydrogen peroxide is produced by peroxidase (PO
D) or by oxidizing the oxidized color indicator to the corresponding dye by means of peroxidase-active substances, the concentration of the color being a measure of the amount of glucose present.
また、血液を検出する際には、ヘモグロビンのべルオキ
シダーゼ様活性によりあらかじめ試験紙などに含まれて
いるベルオキシドから活性酸素が発生し、酸化呈色指示
薬を酸化する。Furthermore, when detecting blood, active oxygen is generated from peroxide contained in test strips etc. in advance due to the peroxidase-like activity of hemoglobin, and oxidizes the oxidized color indicator.
一般に、前記のごとき迅速診断剤の酸化呈色指示薬は、
特定の化合物群類に属し、特に有用なのは、ベンジジン
系、ヘテロ環式アジンおよびフェノール類、特にグアヤ
ク樹脂の成分である(特開昭53−126996号)。Generally, the oxidation color indicator of the above-mentioned rapid diagnostic agent is
Particularly useful belonging to a particular class of compounds are the benzidines, heterocyclic azines and phenols, especially the components of guaiac resin (JP 53-126996).
ところで、最近の加工食品、清涼飲料等にはビタミンC
として多量のアスコルビン酸が含まれており、また健康
管理の点からもビタミン剤等が多量に摂取されている。By the way, recent processed foods, soft drinks, etc. contain vitamin C.
It contains a large amount of ascorbic acid, and vitamins are also taken in large quantities for health management reasons.
従って、血液中には多量のアスコルビン酸が含まれて
おり、しかち、余分なアスコルビン酸は尿中に含有され
て体外に排出されることになる。 このため、前記のご
とき診断剤を用いて尿や血液の試験を行う場合、アスコ
ルビン酸は還元性が強いため、ペルオキシダーゼあるい
はペルオキシダーゼ作用性物質により生成した活性酸素
がアスコルビン酸との酸化還元反応に消費され酸化指示
薬の反応が阻害され、充分な発色が得られないという問
題が生じてきた。Therefore, a large amount of ascorbic acid is contained in the blood, and excess ascorbic acid is contained in the urine and excreted from the body. Therefore, when performing urine or blood tests using diagnostic agents such as those mentioned above, ascorbic acid has strong reducing properties, so active oxygen generated by peroxidase or peroxidase-active substances is consumed in the redox reaction with ascorbic acid. A problem has arisen in that the reaction of the oxidation indicator is inhibited and sufficient color development cannot be obtained.
そこで、本願出願人は、試験剤中に有効量の酸化剤を添
加し、アスコルビン酸等の還元性物質による影響を排除
する旨の技術を開示している(特開昭60−86467
号)。Therefore, the applicant has disclosed a technique in which an effective amount of an oxidizing agent is added to a test agent to eliminate the influence of reducing substances such as ascorbic acid (Japanese Patent Laid-Open No. 60-86467
issue).
しかるに、この試験剤では、空気中の酸素や湿気による
影響で、試験剤(試験具)I使用前の保存中に酸化され
呈色を生じてしまうという欠点がある。However, this test agent has the disadvantage that it is oxidized and discolored during storage prior to use of the test agent (test device) I due to the influence of oxygen and moisture in the air.
〈発明が解決しようとする課題〉
本発明は、上述した従来技術の欠点に鑑みてなされたも
ので、その目的は、保存中の経時変化を防止しつる試験
剤および試験具を提供することにある。<Problems to be Solved by the Invention> The present invention has been made in view of the above-mentioned drawbacks of the prior art, and its purpose is to provide a test agent and a test device that prevent changes over time during storage. be.
く課題を解決するための手段〉
このような目的は、下記(1)〜(8)の本発明により
達成・される。Means for Solving the Problems> These objects are achieved by the present invention described in (1) to (8) below.
(1)ヒドロペルオキシドまたは反応により生ずるヒド
ロペルオキシドを、ペルオキシダーゼまたはペルオキシ
ダーゼ様反応により測定する試験剤、あるいはペルオキ
シダーゼまたはペルオキシダーゼ作用性物質を測定する
試験剤であって、
前記ヒドロペルオキシドが、ペルオキシダーゼまたはペ
ルオキシダーゼ作用性物質の反応下において酸化され発
色する酸化呈色指示薬と、有効量の酸化剤と、下記一般
式■で表わされる安定剤とを有することを特徴とする試
験剤。(1) A test agent for measuring hydroperoxide or a hydroperoxide produced by a reaction using peroxidase or a peroxidase-like reaction, or a test agent for measuring peroxidase or a peroxidase-active substance, wherein the hydroperoxide has peroxidase or peroxidase-active substances. 1. A test agent comprising an oxidized coloring indicator that develops color when oxidized during a reaction with a substance, an effective amount of an oxidizing agent, and a stabilizer represented by the following general formula (2).
一般式■
p4
バゝ
(式中R’ R” R’およびR4は、互いに同一
でも異なっていてもよく、それぞれ、水素原子、低級ア
ルキル基、ハロゲン原子、アミノ基、二トロ基、カルボ
キシル基、またはアルコキシ基を表わす)
(2)前記酸化剤は、MXO4(ただし、Mは一価の陽
イオンとなりうる原子であり、Xはハロゲン原子である
)である上記(1)に記載の試験剤。General formula ■ p4 B (in the formula, R'R''R' and R4 may be the same or different, and each represents a hydrogen atom, a lower alkyl group, a halogen atom, an amino group, a ditro group, a carboxyl group, or represents an alkoxy group) (2) The test agent according to (1) above, wherein the oxidizing agent is MXO4 (M is an atom that can become a monovalent cation, and X is a halogen atom).
(3)前記MXO.がN a I O 4またはHIO
.である上記(2)に記載の試験剤。(3) Said MXO. is N a I O 4 or HIO
.. The test agent according to (2) above.
(4)前記酸化呈色指示薬は、ベンジジン、o−トリジ
ン、3.3’ ,5.5’ −テトラ(低級アルキル)
ベンジジンおよび2,7−ジアミノフルオレンよりなる
群から選ばれたものである上記(1)〜(3)のいずれ
かに記載の試験剤。(4) The oxidized color indicator is benzidine, o-tolidine, 3.3',5.5'-tetra(lower alkyl)
The test agent according to any one of (1) to (3) above, which is selected from the group consisting of benzidine and 2,7-diaminofluorene.
(5)前記安定剤は、2−メルカプトベンズイミダゾー
ルである上記(1)〜(4)のいずれかに記載の試験剤
。(5) The test agent according to any one of (1) to (4) above, wherein the stabilizer is 2-mercaptobenzimidazole.
(6)添加剤として、ポリビニルピロリドンおよびメチ
ルビニルエーテルと無水マレイン酸の共重合体を含む上
記(1)〜(5)のいずれかに記載の試験剤。(6) The test agent according to any one of (1) to (5) above, which contains polyvinylpyrrolidone and a copolymer of methyl vinyl ether and maleic anhydride as additives.
(7)担体に、上記(1)〜(6)のいずれかに記載の
試験剤を担持してなることを特徴とする試験具。(7) A test device comprising a carrier supporting the test agent according to any one of (1) to (6) above.
(8)前記担体の表面に半透過性膜の被覆を有する上記
(7)に記載の試験具。(8) The test device according to (7) above, wherein the surface of the carrier is coated with a semi-permeable membrane.
く具体的構成〉
本発明の試験剤はヒドロペルオキシドまたは前反応によ
って生じる過酸化水素もしくは他のヒドロペルオキシド
を、ペルオキシダーゼまたはペルオキシダーゼ様反応を
用いて測定するもの、またはペルオキシダーゼもしくは
ペルオキシダーゼ作用性物質を測定するものである。Specific constitution> The test agent of the present invention measures hydroperoxide or hydrogen peroxide or other hydroperoxide generated by a pre-reaction using peroxidase or a peroxidase-like reaction, or measures peroxidase or a peroxidase-active substance. It is something.
この試験剤には、アスコルビン酸のごとき還元性物質の
影響を排除すべく、酸化剤が配合される。 この酸化剤
としては、好ましくは酸素酸またはその塩および金属塩
類がある。This test agent contains an oxidizing agent to eliminate the influence of reducing substances such as ascorbic acid. The oxidizing agent preferably includes oxyacids or their salts and metal salts.
酸素酸またはその塩としては、MXO、MXO. M
XO. M.H2 XOa (ただし、Mは一価の
陽イオンとなり得る原子、例えばNa,K,H等であり
、またXはハロゲン原子、例えば、I,Br%Cβ等で
ある)等が挙げられる。Examples of the oxygen acid or its salt include MXO, MXO. M
XO. M. Examples include H2XOa (where M is an atom that can be a monovalent cation, such as Na, K, H, etc., and X is a halogen atom, such as I, Br%Cβ, etc.).
具体例を挙げればHC忍0,NaCβO、KC(20%
HBrO,NaBr’0%KBrO,HIO、NaIO
%KIO、HCf20,N a C Q O s K
C Q O 3H B f” O aN a B r
O s、K B r O s、HIO.、N a I
O sKI03、HCgO.、NaCj204、KC
j204HBrO.、N a B r O 4、
KBrO 4、HIO.N a I 0 4
K I 0 4 N a s H
* I O sK3Hz I Os等がある。
そのなかでもMXO4が好ましく、さらに好ましくはM
IO4であり、最も好ましくはN a I O <また
はHIO4である。Specific examples include HC Shinobu 0, NaCβO, KC (20%
HBrO, NaBr'0% KBrO, HIO, NaIO
%KIO, HCf20, N a C Q O s K
C Q O 3H B f” O aN a B r
O s, K B r O s, HIO. , N a I
OsKI03, HCgO. , NaCj204, KC
j204HBrO. , N a B r O 4,
KBrO 4, HIO. N a I 0 4
K I 0 4 N a s H
* There are IOsK3Hz IOs, etc.
Among them, MXO4 is preferable, and M
IO4, most preferably N a IO < or HIO4.
金属塩類としては、塩化第二鉄、塩化第一銅、硫酸銅、
酢酸銅、酢酸水銀、酢酸ビスマス、酢酸鉛等がある。Metal salts include ferric chloride, cuprous chloride, copper sulfate,
Examples include copper acetate, mercury acetate, bismuth acetate, and lead acetate.
前記酸化剤は、試験剤の保存期間中には酸化呈色支持薬
を酸化しないが、試験に使用するに際しては、検体中に
存在するアスコルビン酸等の還元性物質による酸化指示
薬の反応阻害を防止するのに有効なだけの量が使用され
る。 具体的には、前記試験剤中に含有されている酸化
呈色指示薬および検体中に存在する還元性物質の量に影
響されるが、通常浸漬液に対し0. 3〜100ミリモ
ル/忍程度、好ましくは0. 5〜50ミリモル/I2
程度の濃度である。The oxidizing agent does not oxidize the oxidized color support agent during the storage period of the test agent, but when used in the test, it is necessary to prevent the reaction of the oxidized indicator from being inhibited by reducing substances such as ascorbic acid present in the specimen. Only the amount effective to do so will be used. Specifically, it is affected by the amount of the oxidized color indicator contained in the test agent and the reducing substance present in the specimen, but it is usually 0. 3 to 100 mmol/tolerance, preferably 0. 5-50 mmol/I2
The concentration is about.
酸化されて発色する酸化呈色指示薬(発色剤)は、ペル
オキシダーゼまたはべ゜ルオキシダーゼ様反応によって
生成した酸素の測定系として酸化縮合物を生成する反応
(フェノール系と4−アミノアンチビリン等) メタノ
ールがホルムアルデヒドに酸化され、アセチルアセトン
と縮合物を生成する反応、ヨウ化カリウム等のヨウ化物
が酸化されてヨウ素を生成する反応等に関与するもので
ある。Oxidized color indicators (coloring agents) that develop color when oxidized are used as a measurement system for oxygen generated by peroxidase or bele oxidase-like reactions, such as reactions that produce oxidized condensates (phenol-based and 4-aminoantibiline, etc.), methanol, etc. It is involved in the reaction in which is oxidized to formaldehyde and produces a condensate with acetylacetone, and in the reaction in which iodide such as potassium iodide is oxidized to produce iodine.
酸化呈色指示薬としては、ベンジジン系化合物、ヘテロ
環式アジン類、フェノール類、グアヤク樹脂成分等が挙
げられる。 具体的には、o−トリジン、m−トリジン
、ベンジジン、3,3′、5.5’−テトラ(低級アル
キル)ベンジジン、0−メチルベンジジン,2.7−ジ
アミノフルオレンまたはこれらを種々の割合で含む混合
物4,4゜−ジアミノジフエニル、O−フエニレンジア
ミン、m−フ二二レンジアミン、p−フェニレンジアミ
ン、2.3−トリレンジアミン、2.4−トリレンジア
ミン、2.5−トリレンジアミン、2.6−}リレンジ
アミン等の種々の置換フエニレンジアミン類、焦性没食
子酸、没食子酸、フロログルシノール、ヒドロキノン、
ロイコインドフェノール等のフェノール類、グアイヤコ
ール、ビリジン誘導体、置換アジン類、ロイコマラカイ
トグリーン等がある。 そのなかでも特に、0−トリジ
ン、2.7−ジアミノフルオレンは、安定性に欠けるの
で、後述する安定剤を添加する本発明では、有効性が高
く好ましい。 これらの酸化呈色指示薬は、浸漬液に対
し通常2〜250ミリモル/℃程度、好ましくは10〜
50ミリモル/I;!.程度の濃度で使用される。Examples of the oxidation color indicator include benzidine compounds, heterocyclic azines, phenols, and guaiac resin components. Specifically, o-tolidine, m-tolidine, benzidine, 3,3', 5,5'-tetra(lower alkyl)benzidine, 0-methylbenzidine, 2,7-diaminofluorene or these in various ratios. A mixture containing 4,4°-diaminodiphenyl, O-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2.3-tolylenediamine, 2.4-tolylenediamine, 2.5- Tolylene diamine, various substituted phenylene diamines such as 2.6-}lylene diamine, pyrogallic acid, gallic acid, phloroglucinol, hydroquinone,
Examples include phenols such as leucoindophenol, guaiacol, pyridine derivatives, substituted azines, and leucomalachite green. Among them, 0-tolidine and 2,7-diaminofluorene are especially preferred because they lack stability and are highly effective in the present invention in which a stabilizer described below is added. These oxidized color indicators are usually about 2 to 250 mmol/°C, preferably 10 to 250 mmol/°C, relative to the immersion liquid.
50 mmol/I;! .. It is used at a concentration of about
本発明で使用されるヒドロペルオキシドとしては、ビス
[4−(α−ヒドロペル才キシイソブロビル)ベンジル
]エーテル、2.5−ジメチルヘキサン−2,5−ジヒ
ドロペルオキシド、クメンヒドロペルオキシド、2.5
−ジメチルへキサノン−2.5−ジヒドロペルオキシド
、ジイソブロビルベンゼンヒドロペルオキシド、t−プ
チルヒドロペルオキシド、p−メンタンヒドロペルオキ
シド、4−メチルフェニルイソブロビルヒドロペルオキ
シド等が挙げられる。Hydroperoxides used in the present invention include bis[4-(α-hydroperoxyisobrobyl)benzyl]ether, 2,5-dimethylhexane-2,5-dihydroperoxide, cumene hydroperoxide, 2.5-dimethylhexane-2,5-dihydroperoxide,
-dimethylhexanone-2,5-dihydroperoxide, diisobrobylbenzene hydroperoxide, t-butyl hydroperoxide, p-menthane hydroperoxide, 4-methylphenylisobrobyl hydroperoxide, and the like.
本発明の試験剤に添加される安定剤は、保存中に経時変
化、即ち、空気中の酸素や湿気、光等の要因により酸化
呈色指示薬が酸化され、発色するのを防止する。The stabilizer added to the test agent of the present invention prevents the oxidized coloring indicator from being oxidized and developing color due to changes over time during storage, that is, due to factors such as oxygen, moisture, and light in the air.
この安定剤は、下記一般式工で表わされる物質である。This stabilizer is a substance represented by the general formula below.
一般式I
R4
べ゜
(式中RI Rg R3およびR4は、互いに同一
でも異なっていてもよく、それぞれ、水素原子、低級ア
ルキル基、ハロゲン原子、アミノ基、ニトロ基、カルボ
キシル基、またはアルコキシル基を表わす)
低級アルキル基としては、メチル基、エチル基、プロビ
ル基等の炭素数1〜5のものが挙げられる。General formula I R4 (in the formula, RI Rg R3 and R4 may be the same or different from each other, and each represents a hydrogen atom, a lower alkyl group, a halogen atom, an amino group, a nitro group, a carboxyl group, or an alkoxyl group) Examples of the lower alkyl group include those having 1 to 5 carbon atoms, such as a methyl group, an ethyl group, and a probyl group.
ハロゲン原子としては、F%C℃、Br,I等が挙げら
れる。Examples of the halogen atom include F%C°C, Br, I, and the like.
アルコキシ基としては、メトキシ基、エトキシ基、ブロ
ボキシ基、ブトキシ基等が挙げられる。Examples of the alkoxy group include a methoxy group, an ethoxy group, a broboxy group, a butoxy group, and the like.
式工で示す物質の具体例としては、2−メルカプトベン
ズイミダゾール、2−メルカブトメチルベンズイミダゾ
ール等が挙げられる。 そのなかでも特に2−メルカプ
トベンズイミダゾールが好ましい。 その理由は、2−
メルカプトベンズイミダゾールは安定剤として最も優れ
ており、しかも脂溶性であるため、酸化呈色指示薬の反
応系に悪影響を及ぼさず、またアスコルビン酸を排除す
るための酸化反応系にも、悪影響を及ぼさないからであ
る。Specific examples of the substance shown in the formula include 2-mercaptobenzimidazole, 2-mercaptomethylbenzimidazole, and the like. Among these, 2-mercaptobenzimidazole is particularly preferred. The reason is 2-
Mercaptobenzimidazole is the best stabilizer and is fat-soluble, so it does not have a negative effect on the reaction system of the oxidized color indicator, nor does it have a negative effect on the oxidation reaction system used to eliminate ascorbic acid. It is from.
このような安定剤の添加量は、前記酸化剤の添加量にも
よるが、安定剤としての機能を十分に発揮し、かつ感度
を低下させない量とされる。 これに基づけば、通常浸
漬液に対し、0.1〜5ミリモル72程度、好ましくは
0. 5〜1.5ミリモル/Q程度の濃度で使用され
る。The amount of such a stabilizer added depends on the amount of the oxidizing agent added, but is set to an amount that sufficiently functions as a stabilizer and does not reduce sensitivity. Based on this, about 0.1 to 5 mmol 72, preferably 0.1 to 5 mmol, preferably 0.1 to 5 mmol to the normal immersion liquid. It is used at a concentration of about 5 to 1.5 mmol/Q.
なお、前述した酸化剤を含まない系では前記一般式I以
外の安定剤でも同等の効果を得られるものがあるが、本
発明は酸化剤を含むものであるため,これに適した安定
剤は、前記一般式工に示すものに限られる。In addition, in the above-mentioned system that does not contain an oxidizing agent, the same effect can be obtained with a stabilizer other than the above-mentioned general formula I, but since the present invention contains an oxidizing agent, the suitable stabilizer is the above-mentioned stabilizer. Limited to those shown in General Ceremony.
本発明の試験剤は、試験剤を構或する各薬剤を1つの溶
媒に溶解した溶液、または各薬剤を数パーツに分け、各
パーツを同一または異なる組成の溶媒にそれぞれ溶解し
たものとして使用される。The test agent of the present invention is used as a solution in which each drug constituting the test agent is dissolved in one solvent, or as a solution in which each drug is divided into several parts and each part is dissolved in a solvent with the same or different composition. Ru.
即ち、試験剤は1種の溶液または2種以上の溶液の組み
合わせよりなるものとなる。That is, the test agent consists of one type of solution or a combination of two or more types of solutions.
溶媒としては、例えば、水、ベンゼン、トルエン、キシ
レン、メタノール、エタノール、イソプロパノール、ア
セトン、メチルエチルケトン、クロロホルム、四塩化炭
素等の中から1種ないし2種以上を適宜選択して用いれ
ばよい。As the solvent, one or more solvents may be appropriately selected and used, for example, from water, benzene, toluene, xylene, methanol, ethanol, isopropanol, acetone, methyl ethyl ketone, chloroform, carbon tetrachloride, and the like.
また、溶液の試験剤を乾燥し、粉末状または粒状の試験
剤としてもよい。Alternatively, the solution test agent may be dried to form a powder or granular test agent.
あるいは、後述するように担体に試験剤を担持させた試
験具として使用される。Alternatively, as described below, it is used as a test device in which a test agent is supported on a carrier.
このような試験剤には、必要に応じ、以下述べるような
各種添加剤の添加が許容される。If necessary, various additives as described below may be added to such a test agent.
試験具と検体とを接触(例えば試験具を検体中に浸漬)
した際のpH調整(pH=4〜8、好ましくは5〜7)
のための緩衝剤としては例えばクエン酸−クエン酸ナト
リウム、酒石酸一酒石酸ナトリウム、リンゴ酸−ホウ砂
、フタル酸水素カリウムーフタル酸ジカリウム、コハク
酸水素ナトリウムーコハク酸ジナトリウム等が挙げられ
る。Contact between the test device and the specimen (for example, by dipping the test device into the specimen)
pH adjustment (pH = 4-8, preferably 5-7)
Examples of buffering agents include citric acid-sodium citrate, sodium tartrate-sodium monotartrate, malic acid-borax, potassium hydrogen phthalate-dipotassium phthalate, sodium hydrogen succinate-disodium succinate, and the like.
また、試験具と検体とを接触したとき、検体液が均一に
湿潤(浸透)するように使用される湿潤剤としては、ポ
リビニルピロリドン、ラウリル硫酸ナトリウム、ドデシ
ル硫酸ナトリウム、テトラデシル硫酸ナトリウム等のア
ルキル硫酸塩、ドデシルベンゼンスルホン酸ナトリウム
等のアルキルベンゼンスルホン酸塩、ジオクチルスルホ
コハク酸ナトリウム、ジヘプチルスルホコハク酸ナトリ
ムウ等のジアルキルスルホコハク酸塩等が挙げられる。Wetting agents used to uniformly wet (penetrate) the sample liquid when the test device and sample come into contact include alkyl sulfates such as polyvinylpyrrolidone, sodium lauryl sulfate, sodium dodecyl sulfate, and sodium tetradecyl sulfate. Salts, alkylbenzene sulfonates such as sodium dodecylbenzene sulfonate, dialkyl sulfosuccinates such as sodium dioctyl sulfosuccinate, sodium diheptyl sulfosuccinate, and the like.
このなかでも、特にポリビニルピロリドンは、検体の
浸透を促進させる作用があり、呈色スピードが速くなる
という利点がある。Among these, polyvinylpyrrolidone in particular has the effect of promoting permeation of the specimen and has the advantage of increasing the speed of color development.
また、呈色後の呈色安定性を向上するために、メチルビ
ニルエーテルと無水マレイン酸の共重合体、あるいはそ
のハーフエチルエステル等を添加してもよい。Further, in order to improve the coloring stability after coloring, a copolymer of methyl vinyl ether and maleic anhydride, or a half ethyl ester thereof, etc. may be added.
また、前記試験剤においては、ヘモグロビンにおけるペ
ルオキシダーゼ活性等を増強させる薬剤を添加してもよ
い。 代表的な増強剤としては、キノリンおよびその誘
導体、例えばキニーネ、シンコニン、6−メトキシキノ
リン、キナルジン、8−アミノー6−メトキシキノリン
、2−キノリノール、イソキノリン、ベンゾ(f)キノ
リン、3−アミノキノリン等が挙げられる。 これらの
増強剤が存在すると、通常酸化反応速度が促進され、か
つ酸化された色原体の呈色強度が促進され、試験具の感
度は高められる。Furthermore, in the test agent, a drug that enhances peroxidase activity in hemoglobin, etc. may be added. Typical enhancers include quinoline and its derivatives, such as quinine, cinchonine, 6-methoxyquinoline, quinaldine, 8-amino-6-methoxyquinoline, 2-quinolinol, isoquinoline, benzo(f)quinoline, 3-aminoquinoline, etc. can be mentioned. The presence of these enhancers usually accelerates the oxidation reaction rate and the color intensity of the oxidized chromogen, increasing the sensitivity of the test device.
また、試験具として使用する場合に、担体からの薬剤の
流出を防止するために、粘稠剤を使用してもよい。 代
表的な粘稠剤としては、ポリビニルアルコール、ポリビ
ニルピロリドン、ポリエチレングリコール、アクリル酸
塩、ポリアクリルアミド、ポリ(ヒドロキシエチルメタ
クリレート) ポリ(ヒドロキシエチルアクリレート)
、カルボキシメチルセルロース等の重合体、ゼラチン、
アラビアゴム等が挙げられる。Further, when used as a test device, a thickening agent may be used to prevent the drug from flowing out from the carrier. Typical thickening agents include polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, acrylates, polyacrylamide, poly(hydroxyethyl methacrylate), poly(hydroxyethyl acrylate)
, polymers such as carboxymethylcellulose, gelatin,
Examples include gum arabic.
試験具における担体としては、非繊維性または繊維性の
多孔質材で構成されたものが好ましい。The carrier in the test device is preferably made of a non-fibrous or fibrous porous material.
非繊維性多孔質材としては、濾紙やメンプランフィルタ
ーが代表的であり、その他、珪藻土、微結晶材料等の多
孔体を結合剤中に分散した分散物、ガラスや樹脂の微小
球形ビーズをお互いに点接着させた多孔質の集合体等゛
が挙げられる。Typical examples of non-fibrous porous materials include filter paper and Memplan filters.Other examples include dispersions of porous materials such as diatomaceous earth and microcrystalline materials dispersed in binders, and microspherical beads of glass and resin that are bonded to each other. Examples include porous aggregates that are dot-bonded.
また、繊維性多孔質材としては、織物または編物、不織
布、短繊維の集合体等が挙げられる。Furthermore, examples of the fibrous porous material include woven or knitted fabrics, nonwoven fabrics, short fiber aggregates, and the like.
繊維の素材としては、木綿、絹、ウール等の天然繊維ま
たは、ガラス、ナイロン等の樹脂等が挙げられる。Examples of the fiber material include natural fibers such as cotton, silk, and wool, and resins such as glass and nylon.
試験剤の担持方法としては、試験剤を構成する液体を担
体に含浸(例えば担体を浸漬液に浸漬)させ、その後こ
れを乾燥することにより行えばよい。 液体が2種以上
の場合には、含浸、乾燥を繰り返し行う。The test agent may be supported by impregnating the carrier with a liquid constituting the test agent (for example, by immersing the carrier in an immersion liquid), and then drying the carrier. When there are two or more types of liquids, impregnation and drying are repeated.
また、本発明の試験具は、試験剤を担持した担体の表面
を半透過性膜で被覆したものが好ましい。 この半透過
性膜の存在により、担体の浸透する検体の量を調整する
ことができる。Furthermore, the test device of the present invention preferably has a surface of a carrier carrying a test agent coated with a semi-permeable membrane. The presence of this semipermeable membrane allows the amount of analyte that permeates the carrier to be adjusted.
半透過性膜の構成材料としては、1チルセルロース、カ
ルボキシメチルセルロース等のセルロースエーテル、酢
酸セルロース等のセルロースエステル、イオン交換セル
ロースといったセルロース系材料、あるいは、ボリフッ
化ビニリデン等が挙げられる。Examples of the constituent material of the semipermeable membrane include cellulose ethers such as 1-methyl cellulose and carboxymethyl cellulose, cellulose esters such as cellulose acetate, cellulose-based materials such as ion-exchanged cellulose, and polyvinylidene fluoride.
また、半透過性膜のボアサイズは、0.1〜100一程
度、特に1〜10一程度が好ましい。Further, the bore size of the semipermeable membrane is preferably about 0.1 to 100 mm, particularly about 1 to 10 mm.
また半透過性膜の厚さは、0.1〜to4程度、特に1
〜5一程度が好ましい。The thickness of the semi-permeable membrane is about 0.1 to 4, especially 1 to 4.
~51 is preferred.
このような半透過性膜の形成方法としては、例えば、上
記セルロース系材料を沸点の異なる2種以上の有機溶媒
(例えば、ベンゼン/エタノール)に溶解し、該溶液を
試験剤が担持された担体の表面に塗布するか、または、
該溶液に担体を浸漬し、その後20〜60℃程度にて5
〜20分程度乾燥することにより行われる。A method for forming such a semi-permeable membrane is, for example, by dissolving the above-mentioned cellulose material in two or more organic solvents having different boiling points (e.g., benzene/ethanol), and applying the solution to a carrier carrying a test agent. or apply to the surface of
The carrier was immersed in the solution, and then heated at about 20 to 60°C for 5 minutes.
This is done by drying for about 20 minutes.
この場合、セルロース系材料の有機溶媒に対する量比は
、O.l〜lwt%が好ましい。In this case, the ratio of cellulosic material to organic solvent is O. 1 to 1 wt% is preferable.
本発明の試験剤および試験具は、例えばブドウ糖、尿酸
、コレステロール、トリグリセリド(中性脂肪) 遊離
脂肪酸、ヘモグロビン、ミオグロビン、白血球等の物質
を検出するのに適用される。The test agent and test device of the present invention are applied to detect substances such as glucose, uric acid, cholesterol, triglycerides (neutral fats), free fatty acids, hemoglobin, myoglobin, and white blood cells.
く実施例〉 以下、本発明の具体的実施例について説明する。Example Hereinafter, specific examples of the present invention will be described.
(本発明例1)
下記に示す組成の溶液1、2および3を調製し、濾紙(
東洋社製No.5250)に、まず溶液lを含浸、乾燥
(40℃、60分〉し、次いで溶液2を含浸、乾燥(4
0℃、10分)し、その後溶液3を含浸、乾燥(40℃
、10分)して尿中のブドウ糖検出用試験具を得た。(Example 1 of the present invention) Solutions 1, 2, and 3 having the compositions shown below were prepared, and filter paper (
Toyosha No. 5250), first impregnated with solution 1 and dried (40°C, 60 minutes), then impregnated with solution 2 and dried (4
0°C, 10 minutes), then impregnated with solution 3 and dried (40°C).
, 10 minutes) to obtain a test device for detecting glucose in urine.
なお、この試験具は、尿1dj当り30〜2000mg
のグルコースを定量可能な、青色の呈色を起こすもので
ある。In addition, this test device contains 30 to 2000 mg per 1 dj of urine.
It produces a blue color that can be used to quantify glucose.
溶液1
メタ過ヨウ素酸ナトリウム
(酸化剤)
グルコースオキシダーゼ
ペルオキシダーゼ
タートラジン
10%ポリビニルピロリドン
(K30)水溶液
5%Gantrez ANl39 (メチルビニルエー
テルと無水マレイン酸の共重
合体〉水溶液
クエン酸緩衝液(pH5.5)
溶液2
0−トリジン(酸化呈色指示薬)
2−メルカブトベンズイミダール
(安定剤)
アセトン
溶液3
エチルセルロース
ベンゼンーエタノール(4:1)
150mg
3.0g
100mg
150mg
30m2
70m1
50mj
1.0g
80mg
100ml
550mg
100ml
(比較例1)
溶液2において、2−メルカブトペンズイミダゾールを
含まない以夕「は本発明例1と同様にして尿中のブドウ
糖検出用試験具を得た。Solution 1 Sodium metaperiodate (oxidizing agent) Glucose oxidase Peroxidase Tartrazine 10% Polyvinylpyrrolidone (K30) Aqueous solution 5% Gantrez ANl39 (Copolymer of methyl vinyl ether and maleic anhydride) Aqueous solution Citrate buffer (pH 5.5) Solution 2 0-tolidine (oxidized color indicator) 2-mercabutobenzimidal (stabilizer) Acetone solution 3 Ethylcellulose benzene-ethanol (4:1) 150mg 3.0g 100mg 150mg 30m2 70ml 50mj 1.0g 80mg 100ml 550mg 100ml (Comparative Example 1) A test device for detecting glucose in urine was obtained in the same manner as in Inventive Example 1 except that Solution 2 did not contain 2-mercabutopenzimidazole.
(本発明例2)
下記に示す組成の溶液4、5、6および7を調製し、濾
紙(東洋社製No.5250)に、まず溶液4を含浸、
乾燥(40℃、10分)し、次いで溶液5を含浸、乾燥
(40℃、60分)し、次いで溶液6を含浸、乾燥(4
0℃、10分)し、その後溶液7を含浸、乾燥(40℃
、10分)して尿中の潜血検出用試験具を得た。(Example 2 of the present invention) Solutions 4, 5, 6, and 7 having the compositions shown below were prepared, and a filter paper (No. 5250 manufactured by Toyosha Co., Ltd.) was first impregnated with solution 4.
Dry (40°C, 10 minutes), then impregnate with solution 5, dry (40°C, 60 minutes), then impregnate with solution 6, dry (4
0°C, 10 minutes), then impregnated with solution 7 and dried (40°C).
, 10 minutes) to obtain a test device for detecting occult blood in urine.
溶液4
ビス[4−(α−ヒドロベルオキ
シイソブロビル)ペンジル]エー
テル 800mgジオクチ
ルスルホこはく酸ナトリウ
ム
1,5gエタノール
100ml溶液5
10%ポリビニルピロリドン
(K30)水溶液
5%Gantrez AN139水溶液クエン酸
クエン酸ナトリウム
メタ過ヨウ素酸ナトリウム(酸化
剤)
サボニン
蒸留水
溶液6
o−トリジン(酸化呈色指示薬)
2−メルカプトベンズイミダゾール
(安定剤)
アセトン
溶液7
エチルセルロース
ベンゼンーエタノール(4:1)
100mg
100mg
20ml
1.0g
80mg
100mg
550mg
100mg
(比較例2)
溶液6において、2−メルカブトベ゛ンズイミダゾール
を含まない以外は本発明例2と同様にして尿中の潜血検
出用試験具を得た。Solution 4 Bis[4-(α-hydroberoxyisobrobyl)penzyl]ether 800mg Sodium dioctyl sulfosuccinate
1.5g ethanol
100ml solution 5 10% polyvinylpyrrolidone (K30) aqueous solution 5% Gantrez AN139 aqueous solution Citric acid Sodium citrate Sodium metaperiodate (oxidizing agent) Savonin distilled aqueous solution 6 o-Tolidine (oxidized color indicator) 2-Mercaptobenzimidazole (stable) agent) Acetone solution 7 Ethyl cellulose benzene-ethanol (4:1) 100 mg 100 mg 20 ml 1.0 g 80 mg 100 mg 550 mg 100 mg (Comparative example 2) Same as inventive example 2 except that solution 6 does not contain 2-mercabutobenzimidazole A test device for detecting occult blood in urine was obtained.
(比較例3)
溶液6において、2−メルカプトベンズイミダゾールの
代わりにペンゾイミダゾールを200mg用いた以外は
本発明例2と同様にして尿中の潜血検出用試験具を得た
。(Comparative Example 3) A test device for detecting occult blood in urine was obtained in the same manner as in Inventive Example 2, except that 200 mg of penzimidazole was used instead of 2-mercaptobenzimidazole in Solution 6.
(比較例4)
溶液6において、2−メルカプトベンズイミダゾールの
代わりにメルカブト化合物であるジラウリルチオジブロ
ビオネートを690mg用いた以外は本発明例2と同様
にして尿中の潜血検出用試験具を得た。(Comparative Example 4) A test device for detecting occult blood in urine was prepared in the same manner as in Inventive Example 2, except that in Solution 6, 690 mg of dilaurylthiodibrobionate, which is a mercapto compound, was used instead of 2-mercaptobenzimidazole. Obtained.
上記本発明例l、2、比較例1、2、3、4の各試験具
に対し、保存中の経時変化について調べた。 各試験具
を気温20〜30℃、湿度40〜60%RHの環境で乾
燥剤入り毫のアルミ缶に入れ、放置した。The test devices of Invention Examples 1 and 2 and Comparative Examples 1, 2, 3, and 4 were examined for changes over time during storage. Each test device was placed in an aluminum can containing a desiccant and left in an environment with a temperature of 20 to 30° C. and a humidity of 40 to 60% RH.
本発明例1および2の試験具は、2ケ月経過しても発色
、変色は全く生じなかった。The test devices of Examples 1 and 2 of the present invention showed no color development or discoloration at all even after two months had passed.
これに対し、比較例1および2の試験具は、製造直後に
青色に発色した。In contrast, the test devices of Comparative Examples 1 and 2 developed a blue color immediately after production.
また、比較例3および4の試験具は、いずれも製造直後
に褐色に変色した。Further, both of the test devices of Comparative Examples 3 and 4 turned brown immediately after production.
〈発明の効果〉
以上述べたように、本発明の試験剤および試験具によれ
ば、保存中の経時変化を防止することができる。<Effects of the Invention> As described above, according to the test agent and test device of the present invention, changes over time during storage can be prevented.
出 代 願 理 同 テルモ株式会社Out teenager wish Reason same Terumo Corporation
Claims (8)
ロペルオキシドを、ペルオキシダーゼまたはペルオキシ
ダーゼ様反応により測定する試験剤、あるいはペルオキ
シダーゼまたはペルオキシダーゼ作用性物質を測定する
試験剤であって、 前記ヒドロペルオキシドが、ペルオキシダーゼまたはペ
ルオキシダーゼ作用性物質の反応下において酸化され発
色する酸化呈色指示薬と、有効量の酸化剤と、下記一般
式 I で表わされる安定剤とを有することを特徴とする
試験剤。 一般式 I ▲数式、化学式、表等があります▼ (式中R^1、R^2、R^3およびR^4は、互いに
同一でも異なっていてもよく、それぞれ、水素原子、低
級アルキル基、ハロゲン原子、アミノ基、ニトロ基、カ
ルボキシル基、またはアルコキシ基を表わす)(1) A test agent for measuring hydroperoxide or a hydroperoxide produced by a reaction using peroxidase or a peroxidase-like reaction, or a test agent for measuring peroxidase or a peroxidase-active substance, wherein the hydroperoxide has peroxidase or peroxidase-active substances. 1. A test agent comprising: an oxidized coloring indicator that develops color when oxidized during a reaction with a substance; an effective amount of an oxidizing agent; and a stabilizer represented by the following general formula I. General formula I ▲ Numerical formulas, chemical formulas, tables, etc. , halogen atom, amino group, nitro group, carboxyl group, or alkoxy group)
陽イオンとなりうる原子であり、Xはハロゲン原子であ
る)である請求項1に記載の試験剤。(2) The test agent according to claim 1, wherein the oxidizing agent is MXO_4 (M is an atom that can become a monovalent cation, and X is a halogen atom).
である請求項2に記載の試験剤。(3) The MXO_4 is NaIO_4 or HIO_4
The test agent according to claim 2.
ン、3,3′、5,5′−テトラ(低級アルキル)ベン
ジジンおよび2,7−ジアミノフルオレンよりなる群か
ら選ばれたものである請求項1〜3のいずれかに記載の
試験剤。(4) The oxidized color indicator is selected from the group consisting of benzidine, o-tolidine, 3,3′,5,5′-tetra(lower alkyl)benzidine, and 2,7-diaminofluorene. Item 3. Test agent according to any one of Items 1 to 3.
ルである請求項1〜4のいずれかに記載の試験剤。(5) The test agent according to any one of claims 1 to 4, wherein the stabilizer is 2-mercaptobenzimidazole.
ルビニルエーテルと無水マレイン酸の共重合体を含む請
求項1〜5のいずれかに記載の試験剤。(6) The test agent according to any one of claims 1 to 5, which contains polyvinylpyrrolidone and a copolymer of methyl vinyl ether and maleic anhydride as additives.
を担持してなることを特徴とする試験具。(7) A test device comprising the test agent according to any one of claims 1 to 6 supported on a carrier.
項7に記載の試験具。(8) The test device according to claim 7, wherein the surface of the carrier is coated with a semi-permeable membrane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23814889A JPH03103194A (en) | 1989-09-13 | 1989-09-13 | Testing agent and testing tool |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23814889A JPH03103194A (en) | 1989-09-13 | 1989-09-13 | Testing agent and testing tool |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03103194A true JPH03103194A (en) | 1991-04-30 |
Family
ID=17025904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP23814889A Pending JPH03103194A (en) | 1989-09-13 | 1989-09-13 | Testing agent and testing tool |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03103194A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0553820A2 (en) * | 1992-01-30 | 1993-08-04 | Eiken Kagaku Kabushiki Kaisha | Composition and test strip for measuring peroxidatively active substances |
US5667983A (en) * | 1994-10-24 | 1997-09-16 | Chiron Diagnostics Corporation | Reagents with enhanced performance in clinical diagnostic systems |
WO2002103353A2 (en) * | 2001-06-18 | 2002-12-27 | Nestec Ltd | Threshold glucose detection in urine |
WO2021032103A1 (en) * | 2019-08-19 | 2021-02-25 | 杭州爱光医疗器械有限公司 | Sulfydryl compound detection reagent, test paper, reagent kit, test paper box and preparation thereof |
WO2022054890A1 (en) * | 2020-09-11 | 2022-03-17 | 積水メディカル株式会社 | Method for reducing measurement error |
-
1989
- 1989-09-13 JP JP23814889A patent/JPH03103194A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0553820A2 (en) * | 1992-01-30 | 1993-08-04 | Eiken Kagaku Kabushiki Kaisha | Composition and test strip for measuring peroxidatively active substances |
US5667983A (en) * | 1994-10-24 | 1997-09-16 | Chiron Diagnostics Corporation | Reagents with enhanced performance in clinical diagnostic systems |
US6150128A (en) * | 1994-10-24 | 2000-11-21 | Bayer Corporation | Reagents with enhanced performance in clinical diagnostic systems |
WO2002103353A2 (en) * | 2001-06-18 | 2002-12-27 | Nestec Ltd | Threshold glucose detection in urine |
WO2002103353A3 (en) * | 2001-06-18 | 2003-05-15 | Ralston Purina Co | Threshold glucose detection in urine |
US6682937B2 (en) | 2001-06-18 | 2004-01-27 | Hach Company | Threshold glucose detection in urine |
WO2021032103A1 (en) * | 2019-08-19 | 2021-02-25 | 杭州爱光医疗器械有限公司 | Sulfydryl compound detection reagent, test paper, reagent kit, test paper box and preparation thereof |
WO2022054890A1 (en) * | 2020-09-11 | 2022-03-17 | 積水メディカル株式会社 | Method for reducing measurement error |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6322260B2 (en) | ||
FI71767C (en) | TESTKOMPOSITION OCH TESTANORDNING FOER BESTAEMNING AV GLUKOS I ETT PROV AV VAETSKEFORM SAMT FOERFARANDE FOER SEMIKVANTITATIV BESTAEMNING AV GLUKOS I URIN. | |
US5888758A (en) | Broad range total available chlorine test strip | |
US5976823A (en) | Low range total available chlorine test strip | |
JPS596900A (en) | Analytical element and method of measuring high glucose and method and system for measuring sugar content of whole blood using same | |
US5811254A (en) | Broad range total available chlorine test strip | |
US5491094A (en) | Test strip for free chlorine analysis | |
JPH0317479B2 (en) | ||
JPH0347708B2 (en) | ||
US3654180A (en) | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
HU176045B (en) | Diagnostical composition for determining uric acid | |
EP0158964B1 (en) | Tester for detecting a substance in a body fluid | |
JPH03103194A (en) | Testing agent and testing tool | |
US6087089A (en) | Peroxide and chlorine test strip | |
JPH0429360B2 (en) | ||
JP2950592B2 (en) | Multilayer analytical tool for fructosamine measurement | |
JPS6259782B2 (en) | ||
JPH05260994A (en) | Detection of analyte in saliva using peroxide-peroxidase test system | |
JPH03242539A (en) | Test device and manufacture thereof | |
JP2948654B2 (en) | Test strip for detecting peroxidase active substance | |
JPH0623744B2 (en) | Test piece for nitrite detection | |
US5439827A (en) | Composition for detecting peroxide active material | |
JPS6318703B2 (en) | ||
JPS6361953A (en) | Test piece for detecting peroxide active material | |
JPH04200394A (en) | Test piece for detecting substance having peroxidase action |